BIO-VASCULAR, INC.
EXHIBIT 11.1 - COMPUTATION OF INCOME (LOSS) PER SHARE
(In thousands, except share data)
Year Ended October 31,
----------------------------------------
1995 1994 1993
-------- -------- --------
Per share data:
Net income (loss) $ 2,186 $ (1,880) $ (158)
---------- ---------- ----------
---------- ---------- ----------
Net income (loss) per common and
common equivalent share, primary:
Net income (loss) $ 0.27 $ (.26) $ (.02)
---------- ---------- ----------
---------- ---------- ----------
Net income (loss) per common and common
equivalent share, fully diluted:
Net income (loss) $ 0.27 $ (.26) $ (.02)
---------- ---------- ----------
---------- ---------- ----------
WEIGHTED AVERAGE NUMBER OF COMMON
AND COMMON EQUIVALENT SHARES
Primary:
Weighted average number of common shares
outstanding 7,571,369 7,276,581 7,055,254
Common equivalent shares:
Dilutive stock options and warrants, using
Treasury Stock Method 490,463 -- --
---------- ---------- ----------
8,061,832 7,276,581 7,055,254
---------- ---------- ----------
---------- ---------- ----------
Fully diluted:
Weighted average number of common shares
outstanding 7,571,369 7,276,581 7,055,254
Common equivalent shares:
Dilutive stock options and warrants, using
Treasury Stock Method 601,057 -- --
---------- ---------- ----------
8,172,426 7,276,581 7,055,254
---------- ---------- ----------
---------- ---------- ----------